TP53 and neoplasm: In total, 176/246 MUT in OC (Bonferroni post hoc test P = 0.08239), 19/62 in OP (Bonferroni post hoc test P < 0.000001), 5/9 in HP (Bonferroni post hoc test P = 0.40597) and 78/90 in L (Bonferroni post hoc test P = 0.00002); for the HPV status, 3/30 HPV-positive patients were mutated in TP53 gene; meanwhile, 52/64 were mutated in HPV-negative tumours.